SOSV

Proton Intelligence, founded in 2020 and headquartered in Vancouver, Canada, specializes in biomarker monitoring to manage chronic diseases and enhance patient outcomes. The company focuses on continuous potassium monitoring, particularly for patients suffering from hyperkalemia associated with chronic kidney disease and other co-morbidities. Proton Intelligence's innovative platform provides accurate and real-time potassium measurements through interstitial fluid analysis, which correlates closely with blood levels. This capability is critical for enabling timely and informed decision-making regarding patient care, allowing clinicians and patients to effectively manage medications, dietary choices, and treatment options. By prioritizing precise monitoring, Proton Intelligence aims to significantly improve the health and lives of individuals affected by hyperkalemia.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Bloomlife is a pioneering women's health company focused on enhancing maternal care through innovative technology. By integrating connected devices with cloud-based data analytics, Bloomlife aims to improve access to care for expectant mothers and empower them with crucial information. The company's remote maternal care platform facilitates the monitoring of high-risk pregnancies, allowing obstetricians to better assess maternal and fetal risks and educate patients effectively. Bloomlife’s solutions reduce the need for frequent in-person appointments and lengthy referral processes, thus streamlining the management of pregnancy complications. With a commitment to redefining maternal health, Bloomlife seeks to become the leading provider of remote care for expectant women worldwide, ultimately improving health outcomes for mothers and babies.

OncoPrecision is a biotechnology company focused on enhancing cancer treatment through its innovative patient micro avatar platform. This platform utilizes single-cell high-throughput biology and advanced machine learning techniques to develop comprehensive patient-derived phenotypic biomarkers. By tailoring cancer therapies to individual patients, OncoPrecision aims to significantly increase the success rates of treatments. The company's approach enables oncologists to make informed, data-driven decisions regarding therapy selection based on unique patient samples, thereby improving outcomes in cancer care.

Contextere Corporation, founded in 2015 and based in Ottawa, Canada, is an industrial IoT software company that focuses on enhancing human performance in the workforce. The company offers an intelligent personal agent that provides actionable insights at the last tactical mile, addressing the crucial question of "Now What?" in operational contexts. By leveraging artificial intelligence and machine learning, Contextere's insight engine extracts and structures maintenance, repair, and operations data, making it accessible for users. This technology helps Global 2000 companies improve productivity and safety while minimizing equipment downtime. Through its innovative solutions, Contextere aims to enhance situational awareness and reduce cognitive overload in dynamic data environments.

Feel Therapeutics is a digital precision medicine company focused on mental health. It develops physiological and digital biomarkers, along with therapeutics, to enhance the diagnosis, management, and care of mental health conditions. The company's flagship product is a data monitoring device, which is a wristband equipped with five embedded sensors that collect biometric data. This data is analyzed using advanced computer science techniques to create digital biomarkers. Feel Therapeutics aims to provide objective data and passive monitoring to help users improve their mental well-being and cultivate lasting positive emotional habits through its proprietary algorithms and medical-grade wearables.

Chronus Health, Inc. is a medical technology company that specializes in developing a portable diagnostic device capable of delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and headquartered in Mountain View, California, the company utilizes advanced microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time diagnostic capabilities. This innovative system allows for the delivery of lab results within minutes, significantly enhancing the speed of diagnosis and improving patient outcomes by enabling timely and informed treatment decisions.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Halla is a company that specializes in Taste Intelligence, providing an innovative grocery AI platform designed to understand and respond to consumer preferences and behaviors in real-time. Its suite of products enables grocers to deliver hyper-personalized experiences through tailored product recommendations, substitutions, and search functionalities. By integrating Halla's technology, grocers can enhance customer engagement and drive sales, whether through online cart pages or in-store printed coupons. The platform leverages a combination of food data, human science, and operational insights, utilizing specialized machine-learning models to accurately predict shoppers' individual preferences. This results in a more satisfying grocery experience, encouraging larger purchases and improved customer loyalty.

Feel Therapeutics is a digital precision medicine company focused on mental health. It develops physiological and digital biomarkers, along with therapeutics, to enhance the diagnosis, management, and care of mental health conditions. The company's flagship product is a data monitoring device, which is a wristband equipped with five embedded sensors that collect biometric data. This data is analyzed using advanced computer science techniques to create digital biomarkers. Feel Therapeutics aims to provide objective data and passive monitoring to help users improve their mental well-being and cultivate lasting positive emotional habits through its proprietary algorithms and medical-grade wearables.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Pulse Industrial is a California-based company founded in 2017 that specializes in developing advanced monitoring solutions for industrial plants. The company focuses on creating sensors and devices that provide a comprehensive view of common valves and steam traps, which are critical components of steam generation processes. Pulse Industrial's flagship product, QALM, utilizes artificial intelligence to detect and monitor steam leaks by analyzing vibration and acoustic behavior. This innovative technology enables real-time alerts to maintenance personnel, facilitating timely interventions and enhancing operational safety. By leveraging low power wide area communication, Pulse Industrial's solutions aim to optimize energy efficiency and reduce fuel consumption across various industrial applications.

AuraSense is a company that leverages artificial intelligence and automation to enhance neurological examinations, converting subjective assessments into quantifiable data. By merging video game technology with practical medical procedures, AuraSense develops digital touch technology that enables the early detection of limb damage and facilitates remote physical examinations for various diseases. This innovative approach allows neurologists to accurately evaluate patients' cognitive and physical health, leading to personalized treatment plans tailored to individual needs. Through its technology, AuraSense aims to improve health outcomes and ensure that patients receive effective, data-driven care.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Dia has invented an electrochemical sensor that can measure a wide variety of chemical biomarkers non-invasively in saliva or sweat. The data is sent via Bluetooth to an app on the user’s smartphone and analyzed in real-time. From the app, it can be securely sent to a third party. To date, we have measured hormones, electrolytes, neurotransmitters and metabolites. At DIA, we let the biology dictate which analyte we put on which platform – our wearable arm sleeve for sweat or our table-top device for saliva – because some biomarkers, such as cortisol fluctuate throughout the day and need to be monitored through a wearable sensor, while others, such as creatinine are more suitable to a daily saliva test.

BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.

Halla is a company that specializes in Taste Intelligence, providing an innovative grocery AI platform designed to understand and respond to consumer preferences and behaviors in real-time. Its suite of products enables grocers to deliver hyper-personalized experiences through tailored product recommendations, substitutions, and search functionalities. By integrating Halla's technology, grocers can enhance customer engagement and drive sales, whether through online cart pages or in-store printed coupons. The platform leverages a combination of food data, human science, and operational insights, utilizing specialized machine-learning models to accurately predict shoppers' individual preferences. This results in a more satisfying grocery experience, encouraging larger purchases and improved customer loyalty.

Gaia AI is an MIT spinout focused on revolutionizing forestry management through advanced perception artificial intelligence. By leveraging technology similar to that used in autonomous vehicles, Gaia AI processes LiDAR, camera, and satellite data to enhance the understanding of forest ecosystems. This innovative approach allows for more accurate assessments of carbon stock and timber content, enabling landowners, project developers, and investors to make informed decisions regarding forestry management. Additionally, Gaia AI aims to streamline the evaluation of various forest values, including carbon projects, ecosystem services that support biodiversity, and wildfire risk, ultimately promoting trees as a viable and economically beneficial option for carbon sequestration in the fight against climate change.

Untap Health has developed a pathogen monitoring platform aimed at enhancing community health by detecting infectious diseases through wastewater analysis. The company's innovative tool monitors sewage from various sources, including commercial establishments, schools, and wastewater treatment facilities, allowing for the early identification of viruses before they can lead to outbreaks. By utilizing high-frequency data, Untap Health provides non-invasive and anonymized insights, empowering communities to maintain clean and safe environments through timely warnings when potential health threats are detected.

BizBaz is a provider of financial intelligence solutions tailored for financial institutions, fintech firms, e-commerce, and telecommunications companies across Asia. With teams located in Singapore, Israel, Vietnam, the Philippines, and Malaysia, the company specializes in a comprehensive range of services, including risk assessment, alternative credit scoring, fraud detection, electronic Know Your Customer (eKYC) processes, and financial product aggregation and recommendation systems. BizBaz aims to empower businesses by offering reliable financial and customer intelligence, particularly focusing on engaging unbanked and underserved populations.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Proton Intelligence, founded in 2020 and headquartered in Vancouver, Canada, specializes in biomarker monitoring to manage chronic diseases and enhance patient outcomes. The company focuses on continuous potassium monitoring, particularly for patients suffering from hyperkalemia associated with chronic kidney disease and other co-morbidities. Proton Intelligence's innovative platform provides accurate and real-time potassium measurements through interstitial fluid analysis, which correlates closely with blood levels. This capability is critical for enabling timely and informed decision-making regarding patient care, allowing clinicians and patients to effectively manage medications, dietary choices, and treatment options. By prioritizing precise monitoring, Proton Intelligence aims to significantly improve the health and lives of individuals affected by hyperkalemia.

RxDiet is a company that specializes in nutritional guidance by leveraging artificial intelligence and automation to enhance health outcomes. It has developed a platform that offers personalized meal plans based on individual cultural and lifestyle preferences. By partnering with national food retailers, RxDiet provides users with access to fresh groceries, facilitating healthier dietary choices at reduced costs. Additionally, the company collaborates with major health payers and employers to achieve significant clinical results and cost savings, promoting the concept of "food as medicine" within the healthcare landscape.

Simbe Robotics, Inc. is a San Francisco-based company established in 2014 that specializes in developing and manufacturing autonomous robotic solutions for the retail sector. Its flagship product, Tally, automates the labor-intensive process of shelf auditing by navigating store aisles to assess inventory levels. Tally identifies out-of-stock items, low stock items, misplaced products, and pricing discrepancies, providing valuable data to store staff. The robot operates safely alongside customers and employees during regular store hours, thereby enhancing operational efficiency and accuracy in retail environments.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Gaia AI is an MIT spinout focused on revolutionizing forestry management through advanced perception artificial intelligence. By leveraging technology similar to that used in autonomous vehicles, Gaia AI processes LiDAR, camera, and satellite data to enhance the understanding of forest ecosystems. This innovative approach allows for more accurate assessments of carbon stock and timber content, enabling landowners, project developers, and investors to make informed decisions regarding forestry management. Additionally, Gaia AI aims to streamline the evaluation of various forest values, including carbon projects, ecosystem services that support biodiversity, and wildfire risk, ultimately promoting trees as a viable and economically beneficial option for carbon sequestration in the fight against climate change.

PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring.

Amper Technologies, Inc. is a Chicago-based company founded in 2016 that specializes in developing and operating innovative solutions for manufacturing environments. The company provides a clip-on device designed to analyze power consumption, predict machine downtime, and enable predictive maintenance for factory owners and managers. By offering a comprehensive system that includes non-invasive sensors, an Internet-connected gateway, and web-based dashboards, Amper enhances productivity and overall equipment effectiveness (OEE). Its technology allows plant managers to monitor various machines in real time, facilitating the identification of issues and the unlocking of hidden production capacity. With a focus on user-friendly solutions, Amper empowers manufacturing teams, from operators to plant managers, by providing actionable data and intuitive software, ultimately aiming to transform manufacturing operations into world-class facilities.

Chronus Health, Inc. is a medical technology company that specializes in developing a portable diagnostic device capable of delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and headquartered in Mountain View, California, the company utilizes advanced microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time diagnostic capabilities. This innovative system allows for the delivery of lab results within minutes, significantly enhancing the speed of diagnosis and improving patient outcomes by enabling timely and informed treatment decisions.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Proton Intelligence, founded in 2020 and headquartered in Vancouver, Canada, specializes in biomarker monitoring to manage chronic diseases and enhance patient outcomes. The company focuses on continuous potassium monitoring, particularly for patients suffering from hyperkalemia associated with chronic kidney disease and other co-morbidities. Proton Intelligence's innovative platform provides accurate and real-time potassium measurements through interstitial fluid analysis, which correlates closely with blood levels. This capability is critical for enabling timely and informed decision-making regarding patient care, allowing clinicians and patients to effectively manage medications, dietary choices, and treatment options. By prioritizing precise monitoring, Proton Intelligence aims to significantly improve the health and lives of individuals affected by hyperkalemia.

Proton Intelligence, founded in 2020 and headquartered in Vancouver, Canada, specializes in biomarker monitoring to manage chronic diseases and enhance patient outcomes. The company focuses on continuous potassium monitoring, particularly for patients suffering from hyperkalemia associated with chronic kidney disease and other co-morbidities. Proton Intelligence's innovative platform provides accurate and real-time potassium measurements through interstitial fluid analysis, which correlates closely with blood levels. This capability is critical for enabling timely and informed decision-making regarding patient care, allowing clinicians and patients to effectively manage medications, dietary choices, and treatment options. By prioritizing precise monitoring, Proton Intelligence aims to significantly improve the health and lives of individuals affected by hyperkalemia.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Circadia Health is a technology company focused on enhancing clinical outcomes through its FDA-approved contactless patient monitoring system. This innovative device measures a patient's respiratory rate from a distance of up to eight feet without requiring any physical contact or equipment on the patient. By enabling clinicians to detect potential medical issues such as congestive heart failure, COPD exacerbations, pneumonia, sepsis, urinary tract infections, and falls ahead of time, Circadia Health aims to improve patient care. A dedicated team of virtual nurses continuously analyzes device data alongside patient electronic health records to provide personalized, predictive risk alerts around the clock. This approach not only supports remote assessments but also reduces healthcare costs and enhances overall patient outcomes across various care settings, from hospitals to home environments.

Lucidefi is a developer of a decentralized finance trading terminal that aims to enhance user profitability in the DeFi markets through data provision and execution automation. The company's platform offers a continuously updated list of investment products, powered by a proprietary time-series predictive analytics engine. This technology enables users to access the latest data and trend analysis, facilitating quicker trade executions. Lucidefi's goal is to clarify and simplify the investment process, allowing users to invest efficiently and effectively, thus saving time and maximizing potential returns in the dynamic DeFi landscape.

Untap Health has developed a pathogen monitoring platform aimed at enhancing community health by detecting infectious diseases through wastewater analysis. The company's innovative tool monitors sewage from various sources, including commercial establishments, schools, and wastewater treatment facilities, allowing for the early identification of viruses before they can lead to outbreaks. By utilizing high-frequency data, Untap Health provides non-invasive and anonymized insights, empowering communities to maintain clean and safe environments through timely warnings when potential health threats are detected.

Halla is a company that specializes in Taste Intelligence, providing an innovative grocery AI platform designed to understand and respond to consumer preferences and behaviors in real-time. Its suite of products enables grocers to deliver hyper-personalized experiences through tailored product recommendations, substitutions, and search functionalities. By integrating Halla's technology, grocers can enhance customer engagement and drive sales, whether through online cart pages or in-store printed coupons. The platform leverages a combination of food data, human science, and operational insights, utilizing specialized machine-learning models to accurately predict shoppers' individual preferences. This results in a more satisfying grocery experience, encouraging larger purchases and improved customer loyalty.

BizBaz is a provider of financial intelligence solutions tailored for financial institutions, fintech firms, e-commerce, and telecommunications companies across Asia. With teams located in Singapore, Israel, Vietnam, the Philippines, and Malaysia, the company specializes in a comprehensive range of services, including risk assessment, alternative credit scoring, fraud detection, electronic Know Your Customer (eKYC) processes, and financial product aggregation and recommendation systems. BizBaz aims to empower businesses by offering reliable financial and customer intelligence, particularly focusing on engaging unbanked and underserved populations.

BizBaz is a provider of financial intelligence solutions tailored for financial institutions, fintech firms, e-commerce, and telecommunications companies across Asia. With teams located in Singapore, Israel, Vietnam, the Philippines, and Malaysia, the company specializes in a comprehensive range of services, including risk assessment, alternative credit scoring, fraud detection, electronic Know Your Customer (eKYC) processes, and financial product aggregation and recommendation systems. BizBaz aims to empower businesses by offering reliable financial and customer intelligence, particularly focusing on engaging unbanked and underserved populations.

Mendel is a clinical AI platform for life sciences and healthcare organizations that deciphers health data with clinician-like logic. It indexes structured and unstructured data and replaces the complexity of querying with the simplicity of chatting.

BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.

Simbe Robotics, Inc. is a San Francisco-based company established in 2014 that specializes in developing and manufacturing autonomous robotic solutions for the retail sector. Its flagship product, Tally, automates the labor-intensive process of shelf auditing by navigating store aisles to assess inventory levels. Tally identifies out-of-stock items, low stock items, misplaced products, and pricing discrepancies, providing valuable data to store staff. The robot operates safely alongside customers and employees during regular store hours, thereby enhancing operational efficiency and accuracy in retail environments.

Our AI-powered business intelligence model, provides analysis, predictions, and optimizations that drive our fully integrated e-commerce and digital marketing multiplatform operations for global brands.

Pulse Industrial is a California-based company founded in 2017 that specializes in developing advanced monitoring solutions for industrial plants. The company focuses on creating sensors and devices that provide a comprehensive view of common valves and steam traps, which are critical components of steam generation processes. Pulse Industrial's flagship product, QALM, utilizes artificial intelligence to detect and monitor steam leaks by analyzing vibration and acoustic behavior. This innovative technology enables real-time alerts to maintenance personnel, facilitating timely interventions and enhancing operational safety. By leveraging low power wide area communication, Pulse Industrial's solutions aim to optimize energy efficiency and reduce fuel consumption across various industrial applications.

Stae is a technology company that specializes in developing digital infrastructure platforms for municipalities, aiming to enhance civic data accessibility and usability. By partnering with local governments, Stae enables the integration and management of diverse data sources in real-time, providing city managers and workers with a universal tool for data collaboration. The platform facilitates improved data-sharing workflows, allowing for better performance tracking and informed decision-making. By offering actionable insights, Stae supports cities in navigating compliance, taxation, and procurement challenges in the modern era. Through its innovative solutions, Stae helps cities leverage data to drive operational efficiency and foster innovation.

viAct is an innovative AI company that specializes in providing scenario-based vision intelligence solutions tailored for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Established in 2016, viAct has successfully implemented hundreds of deployments, utilizing its proprietary AI algorithms to deliver detailed insights into job sites. The company's suite of over 30 pre-built AI modules empowers stakeholders to enhance personnel safety, minimize accidents, optimize operational costs, and monitor compliance with environmental regulations. By tracking site activities and assessing safety measures, viAct plays a crucial role in improving efficiency and safety standards within the construction sector.

Chronus Health, Inc. is a medical technology company that specializes in developing a portable diagnostic device capable of delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and headquartered in Mountain View, California, the company utilizes advanced microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time diagnostic capabilities. This innovative system allows for the delivery of lab results within minutes, significantly enhancing the speed of diagnosis and improving patient outcomes by enabling timely and informed treatment decisions.

Journey Foods is a machine learning-driven software platform that serves the packaged food industry, focusing on enhancing product monitoring and development for consumer packaged goods companies, ingredient suppliers, and manufacturers. The company offers enterprise technology designed to streamline innovation and decision-making, enabling food companies to efficiently transition from concept to commercialization. Journey Foods' software provides tools for configuring consumer preferences, generating optimized product formulations, and delivering automated insights on compliance, nutrition, and sustainability. With a robust database containing over 1 billion ingredient insights, Journey Foods utilizes advanced algorithms to offer dynamic analysis and optimized portfolio recommendations based on pricing, supply chain, and nutrition parameters. The platform supports management teams in making informed strategic decisions and facilitates the monitoring of products within the expansive $3 trillion packaged foods market, ultimately improving nutrition, cost efficiency, and sustainability across product lines.

Wayfinder Biosciences is a biotechnology company focused on developing orally available small molecule drugs that target RNA to address key disease areas, including oncology and neurodegenerative disorders. Established in 2021 and headquartered in Seattle, WA, the company utilizes a proprietary platform that integrates advanced screening technologies and computational methods to discover potent and selective RNA-targeting molecules. By employing high-throughput screening combined with machine learning and unique datasets, Wayfinder aims to accelerate the development of therapeutics for traditionally inaccessible targets, enhancing the potential for treating genetic diseases and other challenging conditions.

Feel Therapeutics is a digital precision medicine company focused on mental health. It develops physiological and digital biomarkers, along with therapeutics, to enhance the diagnosis, management, and care of mental health conditions. The company's flagship product is a data monitoring device, which is a wristband equipped with five embedded sensors that collect biometric data. This data is analyzed using advanced computer science techniques to create digital biomarkers. Feel Therapeutics aims to provide objective data and passive monitoring to help users improve their mental well-being and cultivate lasting positive emotional habits through its proprietary algorithms and medical-grade wearables.

Dalton Bioanalytics is a company that specializes in analytical technology aimed at transforming blood analysis and enhancing preventative healthcare. Founded in 2019 and based in Los Angeles, California, Dalton Bioanalytics addresses the inefficiencies and high costs associated with traditional laboratory testing. Its innovative technology digitizes the biochemical composition of blood, allowing for a comprehensive array of health insights derived from a single assay. This capability enables the monitoring of various plasma analytes, including proteins, lipids, electrolytes, and small molecules. By deciphering the biochemical signatures in blood, Dalton Bioanalytics supports the scientific research community in exploring multi-omic biology, thereby facilitating the discovery, development, and delivery of precision medicine.

PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

viAct is an innovative AI company that specializes in providing scenario-based vision intelligence solutions tailored for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Established in 2016, viAct has successfully implemented hundreds of deployments, utilizing its proprietary AI algorithms to deliver detailed insights into job sites. The company's suite of over 30 pre-built AI modules empowers stakeholders to enhance personnel safety, minimize accidents, optimize operational costs, and monitor compliance with environmental regulations. By tracking site activities and assessing safety measures, viAct plays a crucial role in improving efficiency and safety standards within the construction sector.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

RxDiet is a company that specializes in nutritional guidance by leveraging artificial intelligence and automation to enhance health outcomes. It has developed a platform that offers personalized meal plans based on individual cultural and lifestyle preferences. By partnering with national food retailers, RxDiet provides users with access to fresh groceries, facilitating healthier dietary choices at reduced costs. Additionally, the company collaborates with major health payers and employers to achieve significant clinical results and cost savings, promoting the concept of "food as medicine" within the healthcare landscape.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Halla is a company that specializes in Taste Intelligence, providing an innovative grocery AI platform designed to understand and respond to consumer preferences and behaviors in real-time. Its suite of products enables grocers to deliver hyper-personalized experiences through tailored product recommendations, substitutions, and search functionalities. By integrating Halla's technology, grocers can enhance customer engagement and drive sales, whether through online cart pages or in-store printed coupons. The platform leverages a combination of food data, human science, and operational insights, utilizing specialized machine-learning models to accurately predict shoppers' individual preferences. This results in a more satisfying grocery experience, encouraging larger purchases and improved customer loyalty.

Biomage is a company dedicated to advancing life sciences through innovative single-cell analysis. It offers a platform that enables researchers to analyze vast single-cell sequencing data efficiently, transforming complex biological data into actionable insights. This capability supports both academic and industrial scientists in enhancing drug target discovery while reducing costs. The Biomage Single Cell Platform allows users to manage their single-cell data analysis with ease, providing deep biological insights in a streamlined manner. By applying advanced computational methods, Biomage is at the forefront of facilitating groundbreaking research across various biological disciplines.

BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.

OncoPrecision is a biotechnology company focused on enhancing cancer treatment through its innovative patient micro avatar platform. This platform utilizes single-cell high-throughput biology and advanced machine learning techniques to develop comprehensive patient-derived phenotypic biomarkers. By tailoring cancer therapies to individual patients, OncoPrecision aims to significantly increase the success rates of treatments. The company's approach enables oncologists to make informed, data-driven decisions regarding therapy selection based on unique patient samples, thereby improving outcomes in cancer care.

Mendel is a clinical AI platform for life sciences and healthcare organizations that deciphers health data with clinician-like logic. It indexes structured and unstructured data and replaces the complexity of querying with the simplicity of chatting.

Perimeter provides an AI-powered intruder detection system. It can detect an intruder before they enter the premises, and protect the outdoor. It was launched in 2020 and is based in Austin, Texas.

Halla is a company that specializes in Taste Intelligence, providing an innovative grocery AI platform designed to understand and respond to consumer preferences and behaviors in real-time. Its suite of products enables grocers to deliver hyper-personalized experiences through tailored product recommendations, substitutions, and search functionalities. By integrating Halla's technology, grocers can enhance customer engagement and drive sales, whether through online cart pages or in-store printed coupons. The platform leverages a combination of food data, human science, and operational insights, utilizing specialized machine-learning models to accurately predict shoppers' individual preferences. This results in a more satisfying grocery experience, encouraging larger purchases and improved customer loyalty.

MikeLegal is a pioneering company in Asia that specializes in artificial intelligence-driven legal management software, specifically designed to streamline the management of intellectual property tasks. Its primary offerings include solutions for Trademark Public Search, Trademark Journal Watch, and Trademark Portfolio Management. By leveraging AI technology, MikeLegal aims to significantly reduce the time and effort required for these processes, enabling legal teams to lower costs, enhance productivity, and access critical data for informed decision-making. The software features real-time integration, customizable options, and a centralized cloud-based system that automates various trademark-related processes, synchronizes information with registries, and generates detailed reports on legal proceedings. MikeLegal has gained traction with over 100 corporate clients, including prominent companies in various industries.

Pulse Industrial is a California-based company founded in 2017 that specializes in developing advanced monitoring solutions for industrial plants. The company focuses on creating sensors and devices that provide a comprehensive view of common valves and steam traps, which are critical components of steam generation processes. Pulse Industrial's flagship product, QALM, utilizes artificial intelligence to detect and monitor steam leaks by analyzing vibration and acoustic behavior. This innovative technology enables real-time alerts to maintenance personnel, facilitating timely interventions and enhancing operational safety. By leveraging low power wide area communication, Pulse Industrial's solutions aim to optimize energy efficiency and reduce fuel consumption across various industrial applications.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Stae is a technology company that specializes in developing digital infrastructure platforms for municipalities, aiming to enhance civic data accessibility and usability. By partnering with local governments, Stae enables the integration and management of diverse data sources in real-time, providing city managers and workers with a universal tool for data collaboration. The platform facilitates improved data-sharing workflows, allowing for better performance tracking and informed decision-making. By offering actionable insights, Stae supports cities in navigating compliance, taxation, and procurement challenges in the modern era. Through its innovative solutions, Stae helps cities leverage data to drive operational efficiency and foster innovation.

CITYDATA.ai is a developer of a geospatial artificial intelligence platform that simulates the presence and movement of people across 9,000 cities globally. The company utilizes location intelligence to create mobility digital replicas, which quantify population counts and analyze movement patterns. Its platform integrates various products designed to enhance community engagement and data collection, including CITYCOUNT.ai, CITYPARKS.ai, CITYFLOW.ai, CITYSIM.ai, CITYOPS.ai, CITYSURVEY.ai, CITYCHAT.ai, and CITYSDK.ai. These tools enable the collection of mobility data from both public and private sources, facilitating on-site surveys, improving field workforce productivity, and helping brands connect with targeted audiences. Through its citizen apps and chatbots, CITYDATA.ai actively engages residents, providing them with contextual data relevant to their cities while measuring foot traffic and advertising effectiveness.

Kytch is a San Francisco-based company founded in 2018 that specializes in smart connected solutions for quick service restaurants (QSRs). It develops artificial intelligence-powered predictive maintenance software that offers remote control capabilities, real-time data, and analytics. This technology enables clients to monitor machine event sequences and evaluate operational patterns, allowing them to determine the training needs of their employees. By providing insights into equipment functionality, Kytch helps clients minimize downtime and ensure the optimal performance of critical machines, such as ice cream machines, thereby enhancing the efficiency of restaurant operations.

Biomage is a company dedicated to advancing life sciences through innovative single-cell analysis. It offers a platform that enables researchers to analyze vast single-cell sequencing data efficiently, transforming complex biological data into actionable insights. This capability supports both academic and industrial scientists in enhancing drug target discovery while reducing costs. The Biomage Single Cell Platform allows users to manage their single-cell data analysis with ease, providing deep biological insights in a streamlined manner. By applying advanced computational methods, Biomage is at the forefront of facilitating groundbreaking research across various biological disciplines.

Dalton Bioanalytics is a company that specializes in analytical technology aimed at transforming blood analysis and enhancing preventative healthcare. Founded in 2019 and based in Los Angeles, California, Dalton Bioanalytics addresses the inefficiencies and high costs associated with traditional laboratory testing. Its innovative technology digitizes the biochemical composition of blood, allowing for a comprehensive array of health insights derived from a single assay. This capability enables the monitoring of various plasma analytes, including proteins, lipids, electrolytes, and small molecules. By deciphering the biochemical signatures in blood, Dalton Bioanalytics supports the scientific research community in exploring multi-omic biology, thereby facilitating the discovery, development, and delivery of precision medicine.

Our AI-powered business intelligence model, provides analysis, predictions, and optimizations that drive our fully integrated e-commerce and digital marketing multiplatform operations for global brands.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Stae is a technology company that specializes in developing digital infrastructure platforms for municipalities, aiming to enhance civic data accessibility and usability. By partnering with local governments, Stae enables the integration and management of diverse data sources in real-time, providing city managers and workers with a universal tool for data collaboration. The platform facilitates improved data-sharing workflows, allowing for better performance tracking and informed decision-making. By offering actionable insights, Stae supports cities in navigating compliance, taxation, and procurement challenges in the modern era. Through its innovative solutions, Stae helps cities leverage data to drive operational efficiency and foster innovation.

Symphony specializes in predictive maintenance solutions that leverage the Internet of Things and machine learning to enhance operational efficiency. The company has developed sensor devices that wirelessly monitor vibrations from machinery with moving components, transmitting data to the cloud for analysis. Unlike traditional preventative maintenance systems that rely on technicians to interpret raw data, Symphony's approach simplifies the process by delivering actionable alerts directly to facility managers. This allows for quick identification of potential machinery problems, ultimately reducing unscheduled downtime and unnecessary planned maintenance. Facilities can implement Symphony's solution with a modest investment, which is designed to yield significant returns. Once the initial benefits are realized, the system can be easily scaled to monitor additional machines through the installation of more sensors and associated software licenses. By focusing on training AI algorithms rather than human operators, Symphony provides managers with the tools to effectively track machine performance over time, ensuring the smooth operation of industrial processes.

sRNAlytics developed a computational platform to diagnose and subtype disease using small RNAs. We offer our technology and services to drug developers to identify companion diagnostics and uncover new therapeutic targets.

viAct is an innovative AI company that specializes in providing scenario-based vision intelligence solutions tailored for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Established in 2016, viAct has successfully implemented hundreds of deployments, utilizing its proprietary AI algorithms to deliver detailed insights into job sites. The company's suite of over 30 pre-built AI modules empowers stakeholders to enhance personnel safety, minimize accidents, optimize operational costs, and monitor compliance with environmental regulations. By tracking site activities and assessing safety measures, viAct plays a crucial role in improving efficiency and safety standards within the construction sector.

Chronus Health, Inc. is a medical technology company that specializes in developing a portable diagnostic device capable of delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and headquartered in Mountain View, California, the company utilizes advanced microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time diagnostic capabilities. This innovative system allows for the delivery of lab results within minutes, significantly enhancing the speed of diagnosis and improving patient outcomes by enabling timely and informed treatment decisions.

The Futures Agency helps companies, organizations and individuals to better understand.

Esports Charts is a global analytics platform designed to enhance understanding and engagement within the electronic sports (esports) industry. It offers four interconnected services: Streams Charts, Events Charts, Teams Charts, and Games Charts. These services collect and analyze data from various broadcasting platforms, enabling users to track key metrics for channels, streams, communities, events, teams, and games. By providing exhaustive historical data and predictive viewership analytics, Esports Charts aims to increase transparency and trust in esports viewership data, benefiting sponsors, organizers, viewers, gamers, streamers, and businesses alike.

The Futures Agency helps companies, organizations and individuals to better understand.

Journey Foods is a machine learning-driven software platform that serves the packaged food industry, focusing on enhancing product monitoring and development for consumer packaged goods companies, ingredient suppliers, and manufacturers. The company offers enterprise technology designed to streamline innovation and decision-making, enabling food companies to efficiently transition from concept to commercialization. Journey Foods' software provides tools for configuring consumer preferences, generating optimized product formulations, and delivering automated insights on compliance, nutrition, and sustainability. With a robust database containing over 1 billion ingredient insights, Journey Foods utilizes advanced algorithms to offer dynamic analysis and optimized portfolio recommendations based on pricing, supply chain, and nutrition parameters. The platform supports management teams in making informed strategic decisions and facilitates the monitoring of products within the expansive $3 trillion packaged foods market, ultimately improving nutrition, cost efficiency, and sustainability across product lines.

Stae is a technology company that specializes in developing digital infrastructure platforms for municipalities, aiming to enhance civic data accessibility and usability. By partnering with local governments, Stae enables the integration and management of diverse data sources in real-time, providing city managers and workers with a universal tool for data collaboration. The platform facilitates improved data-sharing workflows, allowing for better performance tracking and informed decision-making. By offering actionable insights, Stae supports cities in navigating compliance, taxation, and procurement challenges in the modern era. Through its innovative solutions, Stae helps cities leverage data to drive operational efficiency and foster innovation.

Feel Therapeutics is a digital precision medicine company focused on mental health. It develops physiological and digital biomarkers, along with therapeutics, to enhance the diagnosis, management, and care of mental health conditions. The company's flagship product is a data monitoring device, which is a wristband equipped with five embedded sensors that collect biometric data. This data is analyzed using advanced computer science techniques to create digital biomarkers. Feel Therapeutics aims to provide objective data and passive monitoring to help users improve their mental well-being and cultivate lasting positive emotional habits through its proprietary algorithms and medical-grade wearables.

Amper Technologies, Inc. is a Chicago-based company founded in 2016 that specializes in developing and operating innovative solutions for manufacturing environments. The company provides a clip-on device designed to analyze power consumption, predict machine downtime, and enable predictive maintenance for factory owners and managers. By offering a comprehensive system that includes non-invasive sensors, an Internet-connected gateway, and web-based dashboards, Amper enhances productivity and overall equipment effectiveness (OEE). Its technology allows plant managers to monitor various machines in real time, facilitating the identification of issues and the unlocking of hidden production capacity. With a focus on user-friendly solutions, Amper empowers manufacturing teams, from operators to plant managers, by providing actionable data and intuitive software, ultimately aiming to transform manufacturing operations into world-class facilities.

BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.

AI Nutrition develops an AI that automates online grocery shopping and precision nutrition for better health outcomes.

viAct is an innovative AI company that specializes in providing scenario-based vision intelligence solutions tailored for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Established in 2016, viAct has successfully implemented hundreds of deployments, utilizing its proprietary AI algorithms to deliver detailed insights into job sites. The company's suite of over 30 pre-built AI modules empowers stakeholders to enhance personnel safety, minimize accidents, optimize operational costs, and monitor compliance with environmental regulations. By tracking site activities and assessing safety measures, viAct plays a crucial role in improving efficiency and safety standards within the construction sector.

Dalton Bioanalytics is a company that specializes in analytical technology aimed at transforming blood analysis and enhancing preventative healthcare. Founded in 2019 and based in Los Angeles, California, Dalton Bioanalytics addresses the inefficiencies and high costs associated with traditional laboratory testing. Its innovative technology digitizes the biochemical composition of blood, allowing for a comprehensive array of health insights derived from a single assay. This capability enables the monitoring of various plasma analytes, including proteins, lipids, electrolytes, and small molecules. By deciphering the biochemical signatures in blood, Dalton Bioanalytics supports the scientific research community in exploring multi-omic biology, thereby facilitating the discovery, development, and delivery of precision medicine.

PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring.

sRNAlytics developed a computational platform to diagnose and subtype disease using small RNAs. We offer our technology and services to drug developers to identify companion diagnostics and uncover new therapeutic targets.

NotifAi is a technology company based in Aliso Viejo, California, specializing in the protection of residential properties from water, mold, and appliance-related failures. The company develops a cloud monitoring platform that utilizes Internet of Things (IoT) technology, artificial intelligence, and machine learning to provide real-time alerts for potential issues, such as leaks and appliance malfunctions. Users can deploy sensor devices around critical areas like kitchens, bathrooms, and basements, which continuously monitor for problems. In the event of a detected issue, notifications are sent to both the user and their service provider via text, email, or phone. Founded in 2016, NotifAi aims to enhance asset protection while offering valuable data for preventative maintenance, ultimately helping property owners mitigate risks and potentially lower insurance costs.

Pulse Industrial is a California-based company founded in 2017 that specializes in developing advanced monitoring solutions for industrial plants. The company focuses on creating sensors and devices that provide a comprehensive view of common valves and steam traps, which are critical components of steam generation processes. Pulse Industrial's flagship product, QALM, utilizes artificial intelligence to detect and monitor steam leaks by analyzing vibration and acoustic behavior. This innovative technology enables real-time alerts to maintenance personnel, facilitating timely interventions and enhancing operational safety. By leveraging low power wide area communication, Pulse Industrial's solutions aim to optimize energy efficiency and reduce fuel consumption across various industrial applications.

Antibiotic Adjuvant, Inc. is a healthcare technology company based in Gainesville, Florida, founded in 2014. The company specializes in developing decision support software aimed at reducing infections and antibiotic resistance in healthcare settings. Its flagship product, SmartSteward, provides a comprehensive platform designed to optimize antibiotic use in real-time. The software caters to healthcare administrators by offering tools and educational resources, supports physicians with relevant prescribing information, and assists nurses through surveillance tools and infection reporting mechanisms. Antibiotic Adjuvant's innovative approach seeks to improve the management of antibiotic prescriptions, addressing the complexities of usage patterns and enhancing resistance control in clinical environments.

Oz Content is a SaaS company focused on enhancing content and demand marketing for B2B marketers in small and mid-sized businesses. Its AI-powered software addresses a common challenge faced by these companies: the majority of blog content goes unread by target audiences, resulting in missed sales opportunities. By utilizing advanced audience and keyword targeting, Oz enables clients to significantly reduce the unread rate of their content from 80% to under 10%. The platform facilitates content idea generation through machine learning and predictive analytics, equipping marketers with tools to create effective content efficiently. Furthermore, Oz Content seamlessly integrates with leading marketing automation platforms, enhancing its utility and effectiveness for businesses aiming to generate leads and increase revenue through their blogs.

Halla is a company that specializes in Taste Intelligence, providing an innovative grocery AI platform designed to understand and respond to consumer preferences and behaviors in real-time. Its suite of products enables grocers to deliver hyper-personalized experiences through tailored product recommendations, substitutions, and search functionalities. By integrating Halla's technology, grocers can enhance customer engagement and drive sales, whether through online cart pages or in-store printed coupons. The platform leverages a combination of food data, human science, and operational insights, utilizing specialized machine-learning models to accurately predict shoppers' individual preferences. This results in a more satisfying grocery experience, encouraging larger purchases and improved customer loyalty.

Esports Charts is a global analytics platform designed to enhance understanding and engagement within the electronic sports (esports) industry. It offers four interconnected services: Streams Charts, Events Charts, Teams Charts, and Games Charts. These services collect and analyze data from various broadcasting platforms, enabling users to track key metrics for channels, streams, communities, events, teams, and games. By providing exhaustive historical data and predictive viewership analytics, Esports Charts aims to increase transparency and trust in esports viewership data, benefiting sponsors, organizers, viewers, gamers, streamers, and businesses alike.

Esports Charts is a global analytics platform designed to enhance understanding and engagement within the electronic sports (esports) industry. It offers four interconnected services: Streams Charts, Events Charts, Teams Charts, and Games Charts. These services collect and analyze data from various broadcasting platforms, enabling users to track key metrics for channels, streams, communities, events, teams, and games. By providing exhaustive historical data and predictive viewership analytics, Esports Charts aims to increase transparency and trust in esports viewership data, benefiting sponsors, organizers, viewers, gamers, streamers, and businesses alike.

Chronus Health, Inc. is a medical technology company that specializes in developing a portable diagnostic device capable of delivering rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and headquartered in Mountain View, California, the company utilizes advanced microfluidics and semiconductor technology, combined with data analytics, to provide healthcare providers with real-time diagnostic capabilities. This innovative system allows for the delivery of lab results within minutes, significantly enhancing the speed of diagnosis and improving patient outcomes by enabling timely and informed treatment decisions.